20 June 2013
Keywords: Novo Nordisk, Financial results, R&D update, Diabetes care
Article | 09 August 2012
Denmark’s Novo Nordisk, the world’s largest insulin producer, this morning posted financial results for the second ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 August 2012
19 June 2013
© 2013 thepharmaletter.com